‘Covaxin 81 pc efficient in Phase 3 trials’
Bharat Biotech said the study enrolled participants between 18-98 years, 2,433 over the age of 60 and 4,500 with comorbidities
Bharat Biotech said the study enrolled participants between 18-98 years, 2,433 over the age of 60 and 4,500 with comorbidities
